{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:51:57Z","timestamp":1790261517565,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.carpath.2020.107228","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T21:40:29Z","timestamp":1587073229000},"page":"107228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-7626","authenticated-orcid":false,"given":"Yong-Jian","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lodato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-4558","authenticated-orcid":false,"given":"Richard J.","family":"Castriotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2020.107228_bib0001","unstructured":"World Health Organization. Coronavirus disease (COVID-19) outbreak. April 8, 2020. https:\/\/www.who.int\/westernpacific\/emergencies\/covid-19."},{"key":"10.1016\/j.carpath.2020.107228_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25722","article-title":"Understanding of COVID-19 based on current evidence","author":"Sun","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.carpath.2020.107228_bib0003","unstructured":"Coronavirus disease 2019;(COVID-19) 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/index.html."},{"key":"10.1016\/j.carpath.2020.107228_sbref0002","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","volume":"Published online March 27, 2020","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.carpath.2020.107228_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0006","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.carpath.2020.107228_bib0007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.carpath.2020.107228_bib0008","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.carpath.2020.107228_bib0009","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2020.107228_bib0010","author":"World Health Organization","year":"2003","journal-title":"Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS)"},{"key":"10.1016\/j.carpath.2020.107228_bib0011","unstructured":"World Health Organization. https:\/\/www.who.int\/csr\/don\/08-april-2020-mers-saudi-arabia\/en\/."},{"issue":"11","key":"10.1016\/j.carpath.2020.107228_bib0012","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2020.107228_bib0013","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"issue":"6483","key":"10.1016\/j.carpath.2020.107228_bib0014","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.carpath.2020.107228_sbref0011","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa203","article-title":"Genomic diversity of SARS-CoV-2 in coronavirus disease 2019 patients","author":"Shen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.carpath.2020.107228_sbref0012","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202003-0543OC","article-title":"Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study","author":"Du","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0017","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2014an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.carpath.2020.107228_bib0018","first-page":"17","article-title":"Updating the diagnostic criteria of COVID-19 \u201csuspected case\u201d and \u201cconfirmed case\u201d is necessary","volume":"7","author":"Wang","year":"2020","journal-title":"Mil Med Res"},{"key":"10.1016\/j.carpath.2020.107228_bib0019","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2020.107228_bib0020","first-page":"128","article-title":"Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan","volume":"94","author":"Li","year":"2020","journal-title":"China"},{"key":"10.1016\/j.carpath.2020.107228_bib0021","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.carpath.2020.107228_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.carpath.2020.107228_bib0023","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology","volume":"13","author":"Oudit","year":"2003","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.carpath.2020.107228_bib0024","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.25709","article-title":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV","volume":"92","author":"Liu","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.carpath.2020.107228_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carpath.2020.107228_bib0026","article-title":"Heart injury signs are associated with higher and earlier mortality in coronavirus","author":"Wu","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.carpath.2020.107228_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.carpath.2020.107228_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.carpath.2020.107228_bib0029","doi-asserted-by":"crossref","unstructured":"Yang, X, Yu Y, Xu, J, Shu, H, Xia, J, Liu, H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. 2020.","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"10.1016\/j.carpath.2020.107228_bib0030","article-title":"Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia","author":"Hui","year":"2020","journal-title":"MedR\u03c7iv"},{"issue":"5","key":"10.1016\/j.carpath.2020.107228_bib0031","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.carpath.2020.107228_bib0032","first-page":"87","article-title":"Anatomy and quantification of myocardial cell death","volume":"13","author":"Baroldi","year":"1988","journal-title":"Methods Achiev Exp Pathol"},{"issue":"4","key":"10.1016\/j.carpath.2020.107228_bib0033","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.ATV.16.1.19","article-title":"Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta","volume":"16","author":"Geng","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.carpath.2020.107228_bib0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0171-9335(98)80088-5","article-title":"Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines","volume":"77","author":"Geng","year":"1998","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.carpath.2020.107228_bib0036","doi-asserted-by":"crossref","unstructured":"Zhang B, Zhou X, Qiu Y, Feng F, Feng J, Jia Y, et al. Clinical characteristics of 82 death cases with COVID-19. Medrxiv. https:\/\/doi.org\/10.1101\/2020.02.26.20028191.","DOI":"10.1101\/2020.02.26.20028191"},{"key":"10.1016\/j.carpath.2020.107228_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2019.107153","article-title":"Clinicopathological complexity in the application of the universal definition of myocardial infarction","volume":"44","author":"Buja","year":"2020","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2020.107228_bib0038","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2020.107228_bib0039","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.carpath.2020.107228_bib0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2020.107228_bib0041","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1128\/JVI.02560-09","article-title":"Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.carpath.2020.107228_bib0042","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2020.107228_bib0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.carpath.2020.107228_bib0044","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.RES.0000107195.13573.E4","article-title":"Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells","volume":"94","author":"Kohlstedt","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2020.107228_bib0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","article-title":"Cardiovascular complications of severe acute respiratory syndrome","volume":"82","author":"Yu","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.carpath.2020.107228_bib0046","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.carpath.2020.107228_bib0047","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.carpath.2020.107228_bib0048","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0049","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.carpath.2020.107228_bib0050","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6485","key":"10.1016\/j.carpath.2020.107228_bib0051","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.carpath.2020.107228_bib0052","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2020.107228_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(00)90023-8","article-title":"50th anniversary historical article. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout","volume":"35","author":"Braunwald","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carpath.2020.107228_bib0054","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/CIRCRESAHA.116.308925","article-title":"Myocardial ischemia: lack of coronary blood flow or myocardial oxygen supply\/demand imbalance?","volume":"119","author":"Heusch","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2020.107228_sbref0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.carpath.2020.107228_sbref0048","article-title":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","author":"Wan","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.carpath.2020.107228_bib0057","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.carpath.2020.107228_bib0058","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(03)15326-3","article-title":"Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock","volume":"363","author":"Pathan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2020.107228_bib0059","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.carpath.2020.107228_sbref0052","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.carpath.2020.107228_bib0061","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.carpath.2020.107228_bib0062","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0063","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0064","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa347","article-title":"A community transmitted case of severe acute respiratory distress syndrome due to SARS CoV2 in the United States","author":"Sanville","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.carpath.2020.107228_bib0065","unstructured":"ClinicalTrials.gov. Severe 2019-nCoV Remdesivir RCT. Identifier:NCT04257656. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0066","unstructured":"ClinicalTrials.gov. Mild\/moderate 2019-nCoV Remdesivir RCT. Identifier: NCT04252664. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0067","unstructured":"ClinicalTrials.gov. Study to evaluate the safety and antiviral activity of Remdesivir (GS-5734\u2122) in participants with severe coronavirus disease (COVID-19). Identifier:NCT04292899. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0068","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.carpath.2020.107228_bib0069","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.carpath.2020.107228_bib0070","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.carpath.2020.107228_sbref0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.carpath.2020.107228_bib0072","unstructured":"ClinicalTrials.gov. Efficacy and safety of hydroxychloroquine for treatment of pneumonia caused by 2019-nCoV (HC-nCoV). Identifier:NCT04261517. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0073","unstructured":"ClinicalTrials.gov. Chloroquine\/hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting (COPCOV). Identifier:NCT04303507. 2020."},{"issue":"8","key":"10.1016\/j.carpath.2020.107228_bib0074","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","article-title":"Cardiotoxicity of antimalarial drugs","volume":"7","author":"White","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.carpath.2020.107228_bib0075","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0076","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.carpath.2020.107228_bib0077","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.129.6.1441","article-title":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","volume":"129","author":"Chen","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.carpath.2020.107228_bib0078","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","article-title":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome","volume":"15","author":"Kotch","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"10229","key":"10.1016\/j.carpath.2020.107228_sbref0066","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.carpath.2020.107228_bib0080","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2020.107228_bib0081","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jac\/dki346","article-title":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital","volume":"56","author":"Yeh","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.carpath.2020.107228_sbref0069","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2020.107228_bib0083","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1098\/rstb.2004.1491","article-title":"Management and prevention of SARS in China","volume":"359","author":"Zhong","year":"2004","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.carpath.2020.107228_bib0084","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10565-019-09493-5","article-title":"Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome","volume":"36","author":"Lopes-Pacheco","year":"2020","journal-title":"J Cell Biol Toxicol"},{"key":"10.1016\/j.carpath.2020.107228_bib0085","unstructured":"ClinicalTrials.gov. Anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of COVID-19. Identifier:NCT04292340. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0086","unstructured":"ClinicalTrials.gov. Hyperimmune plasma for critical patients with COVID-19 (COV19-PLASMA). Identifier:NCT04321421. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0087","unstructured":"ClinicalTrials.gov. NestCell\u00ae mesenchymal stem cell to treat patients with severe COVID-19 pneumonia (HOPE). Identifier:NCT04315987. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0088","unstructured":"ClinicalTrials.gov. Treatment with mesenchymal stem cells for severe corona virus disease2019(COVID-19). Identifier:NCT04288102. 2020."},{"key":"10.1016\/j.carpath.2020.107228_bib0089","unstructured":"ClinicalTrials.gov. Treatment and prevention of traditional Chinese medicines (TCMs) on 2019-nCoV infection. Identifier:NCT04251871. 2020."}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880720300326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880720300326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:45:53Z","timestamp":1760960753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880720300326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":89,"alternative-id":["S1054880720300326"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2020.107228","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2020.107228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107228"}}